tiprankstipranks
Trending News
More News >

N4 Pharma PLC Announces Change in Major Shareholdings

Story Highlights
N4 Pharma PLC Announces Change in Major Shareholdings

Confident Investing Starts Here:

N4 Pharma ( (GB:N4P) ) just unveiled an announcement.

N4 Pharma PLC has announced a change in its major holdings, with Mathenz Marc Kay crossing a voting rights threshold to hold 9.12% of the company’s voting rights, up from a previous 8.36%. This change reflects a significant shift in shareholder composition, potentially impacting the company’s governance and strategic decisions.

More about N4 Pharma

N4 Pharma PLC is a pharmaceutical company focused on developing novel delivery systems for vaccines and therapeutics. The company operates within the biotech industry and aims to enhance the effectiveness of existing drugs through its proprietary technologies.

YTD Price Performance: 4.76%

Average Trading Volume: 2,042,705

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: £5.97M

For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App